πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8715645

Viral vectors encoding apoptosis-inducing proteins and methods for making and using the sa

The Regents of the University of Colorado Β· Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8716246

Azuvirin peptides

The Regents of the University of California Β· Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8715689

Chimeric west nile/dengue viruses

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8709443

Reovirus for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. Β· Granted Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8703938

Hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8703735

Antisense antiviral compounds and methods for treating a filovirus infection

Sarepta Therapeutics, Inc. Β· Granted Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8697704

Hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. Β· Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8697858

Antisense antiviral compound and method for treating influenza viral infection

Sarepta Therapeutics, Inc. Β· Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8691241

Reoviruses having modified sequences

ONCOLYTICS BIOTECH INC. Β· Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8685411

Rotavirus antigens

The United States of America as represented by the Dept. of Health and Human Services (DHHS) Β· Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8685722

Bovine adeno-associated viral (BAAV) vector and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8685734

Viral purification methods

ONCOLYTICS BIOTECH INC. Β· Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8680046

Inhibitors of viral integrase and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8680065

Oligonucleotides of human endogenous retrovirus 9 (ERV-9) long terminal repeat (LTR) and m

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8674118

Compounds and methods for the treatment or prevention of flavivirus infections

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8673316

Avirulent, immunogenic flavivirus chimeras

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION Β· Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8673629

Recombinant Rift Valley fever (RVF) viruses and methods of use

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8664273

Treatment of hepatitis C virus with telaprevir (VX-950) in patients non-responsive to trea

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8663950

Production of a monoclonal antibody therapeutic against west nile virus in plants

THE ARIZONA BOARD OF REGENTS Β· Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8663968

Simian T-cell lymphotropic virus

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8663624

Adeno-associated virus virions with variant capsid and methods of use thereof

The Regents of the University of California Β· Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8663622

Recombinant vaccine viruses expressing IL-15 and methods using the same

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8658674

Thiophene analogues for the treatment or prevention of flavivirus infections

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8658616

Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of h

University College Cardiff Consultants Limited Β· Granted Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted